Sponsor:
Starx Research Center, LLC
Code:
NCT01808768
Conditions
Allergic Conjunctivitis
Rhinoconjunctivitis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alcaftadine
Brief summary:
Conditions
Allergic Conjunctivitis
Rhinoconjunctivitis
Study ID
NCT01808768
Start date
Apr, 2013
Status verified date
Mar, 2013
Completion date
Nov, 2013
Anticipated
Primary completion date
Oct, 2013
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Alcaftadine
Interventions
Alcaftadine
Primary outcome measure
Central contacts
Locations
STARx Research Center
Recruiting
Edison, New Jersey, United States, 08820
Contacts
Principal Investigator:
Jayesh Kanuga, MD
STARx
Recruiting
Springfield, New Jersey, United States, 07081
Contacts
Sponsor
Starx Research Center, LLC
Last update posted
May 30, 2013
Last verified
Mar, 2013
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Starx Research Center, LLC on 2013-05-30.